Disulfide-rich peptides represent a diverse family of bioactive molecules which have been developed as drugs for the treatment of severe pain. This project seeks to understand their biosynthesis and how their functional diversity is generated. Such information will assist the translation of more of these novel peptides into new drugs.
|Effective start/end date||1/01/13 → 30/04/14|
- Australian Research Council (ARC): AUD120,496.00